20571060| pmc = }}</ref> is a [[cannabinoid]] drug, which acts as a potent [[agonist]] at both the [[Cannabinoid receptor type 1|CB<sub>1</sub>]] and [[Cannabinoid receptor type 2|CB<sub>2</sub>]] receptors, but has poor [[blood–brain barrier]] penetration, and so produces only peripheral effects at low doses, with symptoms of central effects such as [[catalepsy]] only appearing at much higher dose ranges. It has [[hyperalgesia|antihyperalgesic]] properties in animal studies,<ref>{{Cite journal | last1 = Dziadulewicz | first1 = E. K. | last2 = Bevan | first2 = S. J. | last3 = Brain | first3 = C. T. | last4 = Coote | first4 = P. R. | last5 = Culshaw | first5 = A. J. | last6 = Davis | first6 = A. J. | last7 = Edwards | first7 = L. J. | last8 = Fisher | first8 = A. J. | last9 = Fox | first9 = A. J. | last10 = Gentry | doi = 10.1021/jm070317a | first10 = C. | last11 = Groarke | first11 = A. | last12 = Hart | first12 = T. W. | last13 = Huber | first13 = W. | last14 = James | first14 = I. F. | last15 = Kesingland | first15 = A. | last16 = La Vecchia | first16 = L. | last17 = Loong | first17 = Y. | last18 = Lyothier | first18 = I. | last19 = McNair | first19 = K. | last20 = O'Farrell | first20 = C. | last21 = Peacock | first21 = M. | last22 = Portmann | first22 = R. | last23 = Schopfer | first23 = U. | last24 = Yaqoob | first24 = M. | last25 = Zadrobilek | first25 = J. | title = Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone:  A Potent, Orally Bioavailable Human CB1/CB2Dual Agonist with Antihyperalgesic Properties and Restricted Central Nervous System Penetration | journal = Journal of Medicinal Chemistry | volume = 50 | issue = 16 | pages = 3851–3856 | year = 2007 | pmid =  17630726| pmc = }}</ref> and has progressed to preliminary human trials.<ref name="pmid19144772">{{cite journal |vauthors=Gardin A, Kucher K, Kiese B, Appel-Dingemanse S |title=Cannabinoid receptor agonist 13, a novel cannabinoid agonist: first in human pharmacokinetics and safety |journal=Drug Metabolism and Disposition: the Biological Fate of Chemicals |volume=37 |issue=4 |pages=827–33 |date=April 2009 |pmid=19144772 |doi=10.1124/dmd.108.024000 |url= |issn=}}</ref>
